• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for mortality in critically ill patients with COVID-19 in Huanggang, China: A single-center multivariate pattern analysis.中国黄冈 COVID-19 重症患者死亡的危险因素:一项单中心多变量模式分析。
J Med Virol. 2021 Apr;93(4):2046-2055. doi: 10.1002/jmv.26572. Epub 2020 Oct 14.
2
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.成都 32 例危重症和 67 例非危重症 COVID-19 的流行病学特征和临床特征。
J Clin Virol. 2020 Jun;127:104366. doi: 10.1016/j.jcv.2020.104366. Epub 2020 Apr 10.
3
Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.东京重症 COVID-19 患者的临床特征和结局:来自第一波的单中心观察性研究。
BMC Infect Dis. 2021 Feb 9;21(1):163. doi: 10.1186/s12879-021-05840-2.
4
Identifying and quantifying robust risk factors for mortality in critically ill patients with COVID-19 using quantile regression.利用分位数回归识别和量化 COVID-19 危重症患者死亡率的稳健风险因素。
Am J Emerg Med. 2021 Jul;45:345-351. doi: 10.1016/j.ajem.2020.08.090. Epub 2020 Sep 3.
5
The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.改良的 NUTRIC 评分可用于危重症 COVID-19 患者的营养风险评估和预后预测。
Clin Nutr. 2021 Feb;40(2):534-541. doi: 10.1016/j.clnu.2020.05.051. Epub 2020 Jun 5.
6
Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.需要高氧流量的危重症COVID-19患者死亡的预测因素:炎症、细胞因子风暴和凝血病之间的微妙界限
Oxid Med Cell Longev. 2021 Apr 20;2021:6648199. doi: 10.1155/2021/6648199. eCollection 2021.
7
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.中国新型冠状病毒传染病(COVID-19)危重症患者的临床特征和结局:一项回顾性多中心研究。
Intensive Care Med. 2020 Oct;46(10):1863-1872. doi: 10.1007/s00134-020-06211-2. Epub 2020 Aug 20.
8
Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study.体外膜肺氧合治疗武汉危重新冠病毒病 2019 患者:一项回顾性多中心队列研究。
Curr Med Sci. 2021 Feb;41(1):1-13. doi: 10.1007/s11596-021-2311-8. Epub 2021 Feb 13.
9
Risk factors for mortality of critically ill patients with COVID-19 receiving invasive ventilation.COVID-19 重症患者接受有创通气治疗的死亡风险因素。
Int J Med Sci. 2021 Jan 11;18(5):1198-1206. doi: 10.7150/ijms.50039. eCollection 2021.
10
Clinical characteristics and risk factors for mortality in patients with coronavirus disease 2019 in intensive care unit: a single- center, retrospective, observational study in China.中国某单中心回顾性观察性研究:重症监护病房 2019 冠状病毒病患者的临床特征和死亡危险因素。
Ann Palliat Med. 2021 Mar;10(3):2859-2868. doi: 10.21037/apm-20-1575. Epub 2021 Feb 5.

引用本文的文献

1
Association Between Artificial Intelligence Based Chest Computed Tomography and Clinical/Laboratory Characteristics with Severity and Mortality in COVID-19 Hospitalized Patients.基于人工智能的胸部计算机断层扫描与新冠病毒住院患者的临床/实验室特征、严重程度及死亡率之间的关联
J Inflamm Res. 2024 May 14;17:2977-2989. doi: 10.2147/JIR.S456440. eCollection 2024.
2
Dysphagia Is an Underrecognized Risk Factor for Viral Pneumonia Severity.吞咽困难是病毒性肺炎严重程度的一个未被充分认识的风险因素。
Dysphagia. 2024 Dec;39(6):1156-1162. doi: 10.1007/s00455-024-10697-z. Epub 2024 Apr 27.
3
Machine learning-based mortality prediction models for smoker COVID-19 patients.基于机器学习的吸烟者 COVID-19 患者死亡率预测模型。
BMC Med Inform Decis Mak. 2023 Jul 21;23(1):129. doi: 10.1186/s12911-023-02237-w.
4
Predicting Mortality in Hospitalized COVID-19 Patients in Zambia: An Application of Machine Learning.预测赞比亚住院 COVID-19 患者的死亡率:机器学习的应用。
Glob Health Epidemiol Genom. 2023 May 22;2023:8921220. doi: 10.1155/2023/8921220. eCollection 2023.
5
Intensive Care and Organ Support Related Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis.2019冠状病毒病患者的重症监护与器官支持相关死亡率:一项系统评价与荟萃分析
Crit Care Explor. 2023 Mar 3;5(3):e0876. doi: 10.1097/CCE.0000000000000876. eCollection 2023 Mar.
6
Predicting the Need for Intubation among COVID-19 Patients Using Machine Learning Algorithms: A Single-Center Study.使用机器学习算法预测COVID-19患者的插管需求:一项单中心研究。
Med J Islam Repub Iran. 2022 Apr 4;36:30. doi: 10.47176/mjiri.36.30. eCollection 2022.
7
Machine Learning Models to Predict In-Hospital Mortality among Inpatients with COVID-19: Underestimation and Overestimation Bias Analysis in Subgroup Populations.机器学习模型预测 COVID-19 住院患者院内死亡率:亚组人群中的低估和高估偏差分析。
J Healthc Eng. 2022 Jun 23;2022:1644910. doi: 10.1155/2022/1644910. eCollection 2022.
8
An interpretable machine learning model based on a quick pre-screening system enables accurate deterioration risk prediction for COVID-19.基于快速预筛选系统的可解释机器学习模型可准确预测 COVID-19 恶化风险。
Sci Rep. 2021 Nov 30;11(1):23127. doi: 10.1038/s41598-021-02370-4.
9
Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score.简单的人口统计学特征和入院时的实验室检查结果可能预测 SARS-CoV-2 感染患者的住院死亡率:covid-19 评分的制定和验证。
BMC Infect Dis. 2021 Sep 14;21(1):945. doi: 10.1186/s12879-021-06645-z.
10
Mortality and Clinical Interventions in Critically ill Patient With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.2019年冠状病毒病重症患者的死亡率及临床干预措施:一项系统评价与荟萃分析
Front Med (Lausanne). 2021 Jul 23;8:635560. doi: 10.3389/fmed.2021.635560. eCollection 2021.

本文引用的文献

1
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
2
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.严重新型冠状病毒肺炎与非新型冠状病毒肺炎患者凝血功能特征的差异。
J Thromb Thrombolysis. 2021 May;51(4):1107-1110. doi: 10.1007/s11239-020-02105-8.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
COVID-19 battle during the toughest sanctions against Iran.在对伊朗最严厉制裁期间的新冠疫情防控战。
Lancet. 2020 Mar 28;395(10229):1035-1036. doi: 10.1016/S0140-6736(20)30668-1. Epub 2020 Mar 18.
5
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
6
COVID-19 and Italy: what next?COVID-19 和意大利:下一步如何?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.

中国黄冈 COVID-19 重症患者死亡的危险因素:一项单中心多变量模式分析。

Risk factors for mortality in critically ill patients with COVID-19 in Huanggang, China: A single-center multivariate pattern analysis.

机构信息

Department of Nephrology and Laboratory of Kidney Disease, Hunan Provincial People's Hospital, Hunan Normal University, Changsha, China.

Changsha Clinical Research Center for Kidney Disease, Changsha, China.

出版信息

J Med Virol. 2021 Apr;93(4):2046-2055. doi: 10.1002/jmv.26572. Epub 2020 Oct 14.

DOI:10.1002/jmv.26572
PMID:32997344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7537509/
Abstract

To date, the coronavirus disease 2019 (COVID-19) has a worldwide distribution. Risk factors for mortality in critically ill patients, especially detailed self-evaluation indicators and laboratory-examination indicators, have not been well described. In this paper, a total of 192 critically ill patients (142 were discharged and 50 died in the hospital) with COVID-19 were included. Self-evaluation indicators including demographics, baseline characteristics, and symptoms and detailed lab-examination indicators were extracted. Data were first compared between survivors and nonsurvivors. Multivariate pattern analysis (MVPA) was performed to identify possible risk factors for mortality of COVID-19 patients. MVPA achieved a relatively high classification accuracy of 93% when using both self-evaluation indicators and laboratory-examination indicators. Several self-evaluation factors related to COVID-19 were highly associated with mortality, including age, duration (time from illness onset to admission), and the Barthel index (BI) score. When the duration, age increased by 1 day, 1 year, BI decreased by 1 point, the mortality increased by 3.6%, 2.4%, and 0.9% respectively. Laboratory-examination indicators including C-reactive protein, white blood cell count, platelet count, fibrin degradation products, oxygenation index, lymphocyte count, and d-dimer were also risk factors. Among them, duration was the strongest predictor of all-cause mortality. Several self-evaluation indicators that can simply be obtained by questionnaires and without clinical examination were the risk factors of all-cause mortality in critically ill COVID-19 patients. The prediction model can be used by individuals to improve health awareness, and by clinicians to identify high-risk individuals.

摘要

截至目前,2019 年冠状病毒病(COVID-19)已在全球范围内传播。危重症患者的死亡风险因素,特别是详细的自我评估指标和实验室检查指标,尚未得到很好的描述。本文共纳入 192 例 COVID-19 危重症患者(出院 142 例,院内死亡 50 例)。提取了自我评估指标,包括人口统计学、基线特征、症状和详细的实验室检查指标。首先比较了存活者和非存活者之间的数据。采用多变量模式分析(MVPA)来识别 COVID-19 患者死亡的可能风险因素。MVPA 在使用自我评估指标和实验室检查指标时达到了相对较高的 93%的分类准确率。几个与 COVID-19 相关的自我评估因素与死亡率高度相关,包括年龄、持续时间(从发病到入院的时间)和巴氏指数(BI)评分。当持续时间、年龄增加 1 天、1 年,BI 减少 1 分时,死亡率分别增加 3.6%、2.4%和 0.9%。实验室检查指标包括 C 反应蛋白、白细胞计数、血小板计数、纤维蛋白降解产物、氧合指数、淋巴细胞计数和 D-二聚体也是风险因素。其中,持续时间是所有原因死亡率的最强预测因素。几个可以通过问卷简单获得且无需临床检查的自我评估指标是 COVID-19 危重症患者全因死亡率的危险因素。预测模型可由个人使用以提高健康意识,由临床医生用于识别高风险个体。